News

3/16/2023
Providence Hood River, Providence Portland and Providence St. Vincent each earned Healthgrades honors for outstanding patient experience. Providence Medford was honored for patient safety excellence.
3/14/2023
New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.
3/17/2023
In honor of Social Work Month we recognize the incredible contributions of oncology social workers.
2/28/2023
Hitting the slopes can be a fun and healthy activity, but there can be risks. Dr. Christopher Van Tilburg, with the Providence Hood River Memorial Hospital Mountain Clinic, talks mountain safety.
2/15/2023
A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.
1/30/2023
Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.
1/17/2023
For third year in a row, Providence St. Vincent Medical Center has received America’s 50 Best Hospitals Award. This recognition places Providence among the top 1% of the country's hospital
1/13/2023
A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
12/20/2022
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
12/8/2022
Many emergency rooms, clinics and urgent care centers are experiencing a sharp rise in the number of cases of RSV, flu and COVID.
12/6/2022
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.
Powered by Translations.com GlobalLink OneLink SoftwarePowered By OneLink